Aspire BioPharma, Inc. (ASBP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $8.98 (-1.54%), Market cap $0.01B, 52-week low–high $1.56 ~ $66.30.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration
Financial statements, price targets, institutional (13F) holdings and related news for Aspire BioPharma, Inc. are updated in real time on BlackAll Trade.
Aspire BioPharma, Inc. trades at $8.98 (-1.54%). Real-time quotes and charts are available on BlackAll Trade.
Aspire BioPharma, Inc. has a market cap of about $0.01B.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingua